Measures of quality of life: pro

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002:3 Suppl 1:S19. doi: 10.1080/146608202320374174.

Author

Albert C Ludolph¹

Affiliation

¹ Department of Neurology, University of Ulm, Germany.

PMID: 12396796
DOI: 10.1080/146608202320374174

No abstract available

MeSH terms

Amyotrophic Lateral Sclerosis / drug therapy
Amyotrophic Lateral Sclerosis / physiopathology
Amyotrophic Lateral Sclerosis / psychology*
Clinical Trials as Topic
Endpoint Determination
Humans
Neuroprotective Agents / adverse effects
Neuroprotective Agents / therapeutic use
Quality of Life / psychology*
Riluzole / adverse effects
Riluzole / therapeutic use
Survival Analysis

Substances

Neuroprotective Agents
Riluzole